Retatrutide research: three receptor pathways explained
A research-first introduction to GIP, GLP-1, and glucagon receptor targets—and what makes the profile distinct.
Retatrutide, also known as LY3437943, is a single peptide studied for agonist activity at the GIP, GLP-1, and glucagon receptors. That three-target profile is the basis for the phrase “triple receptor agonist.”
Three research targets
- GIP receptor: glucose-dependent insulinotropic polypeptide signalling.
- GLP-1 receptor: glucagon-like peptide-1 signalling.
- Glucagon receptor: glucagon-pathway signalling.
Why the distinction matters
Semaglutide research centres on GLP-1 receptor activity. Tirzepatide research examines GIP and GLP-1. Retatrutide adds glucagon-receptor activity to the research profile. This describes molecular targets—not personal outcomes or medical guidance.
Explore the Retatrutide research profile →
Separate the molecule from the listing
A paper describing a named investigational molecule does not authenticate a vial sold under the same name. Keep the published research record separate from the supplier’s identity testing, lot information and material specification. Each answers a different question.
A practical way to read a receptor study
Write down the experimental model, the receptor being measured, the comparator and the actual endpoint. A receptor-binding experiment, a functional signalling assay and a clinical trial do not measure the same thing. Ask whether a claim describes target activity or a demonstrated outcome in a specific study.
For example, “three receptor targets” is a description of the molecule’s intended pharmacology. It is not a ranking that means three is always better than one or two. Study design and the evidence needed for each conclusion still matter.
Related reading
Sources and scope
Sources support the scientific or analytical concepts discussed. They do not certify Reforge products, establish their suitability for a particular study, or imply endorsement by the source organizations. Pharmaceutical guidance is cited for context, not as proof that a research material meets medicinal-product standards.
For laboratory research use only. Not for human or veterinary use.